Clinical Trials Using Ulocuplumab

Clinical trials are research studies that involve people. The clinical trials on this list are studying Ulocuplumab. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Ulocuplumab and Ibrutinib in Treating Patients with Mutated CXCR4 Waldenstrom Macroglobulinemia

    This phase I / II trial studies the best dose of ulocuplumab when given together with ibrutinib and to see how well they work in treating patients with mutated CXCR4 Waldenstrom macroglobulinemia. Immunotherapy with ulocuplumab, may induce changes in body’s immune system and may interfere with the ability of tumor cells to grow and spread. Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving ulocuplumab and ibrutinib may work better in treating patients with Waldenstrom macroglobulinemia.
    Location: 3 locations